Back
Speaker illustration

undefined undefined undefined

Sessions Presentations Articles

Applying ODYSSEY Outcomes in your clinical practice - Who are the most appropriate patients for PCSK9 inhibitor treatment?

Event: ESC Congress 2019

Topic: Acute Coronary Syndromes

Session type: Satellite Symposium - Experts on the Spot

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources